New obesity Drug's impact on heart meds under the microscope
NCT ID NCT06289504
First seen May 19, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study tested how CagriSema, a drug for weight management, changes the way the body processes two common medications: atorvastatin (for cholesterol) and warfarin (a blood thinner). Thirty-four adults with overweight or obesity took these medications before and after starting CagriSema to measure any differences in drug levels and effects. The goal was to gather safety information, not to treat the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Company Inc.
Montreal, Quebec, H3P 3P1, Canada
Conditions
Explore the condition pages connected to this study.